Resource Center

Media

New Webinar on Dec 04: The Power of Microbial Cell-Free DNA: Real World Application of a Liquid Biopsy for Febrile Neutropenia. Register today

From a single blood sample, the Karius Test can non-invasively and rapidly detect over 1000 pathogens causing both deep-seated and bloodstream infections.

Karius

This webinar explores the application of metagenomic sequencing of plasma microbial cell-free DNA for the detection of pathogens associated with febrile neutropenia. The Karius Test, a liquid biopsy for infectious diseases, utilizes a single blood sample to identify over 1000 pathogens for various diagnostic purposes, including fever of unknown origin, invasive fungal infections, pneumonia, endocarditis, and febrile neutropenia. Our featured speaker, Dr. Negar Ashouri, reviews some of the published data and shares insights on the optimal use of the Karius Test for febrile neutropenia. Dr. Ashouri also shares some of her own patient cases describing the clinical impact of the Karius Test in febrile neutropenia.

Director, Antimicrobial Stewardship Chair, Infection Prevention Committee, Children's Hospital of Orange County

The Power of Microbial Cell-Free DNA: Real World Application of A Liquid Biopsy for Febrile Neutropenia

Listen to this lively discussion from a panel of leading infectious disease specialists on optimal implementation and utilization of metagenomic sequencing of microbial cell-free DNA. During this event the panel explores the comparative benefits of the Karius Test to traditional methods and emphasizes how this test has complimented and enhanced their diagnostic workflows. The panel also shares their personal experiences describing how the Karius Test has helped to improve clinical outcomes for their most vulnerable patients across a variety of use cases and patient populations.

Harnessing Microbial Insights: How Metagenomic Sequencing of Microbial Cell-Free DNA is Transforming Infectious Disease Diagnostics

This webinar will explore the application of metagenomic next-generation sequencing of plasma microbial cell-free DNA for the detection of pathogens associated with fever of unknown origin. The Karius Test, a liquid biopsy for infectious diseases, utilizes a single blood sample to identify over 1000 pathogens for various diagnostic purposes, including fever of unknown origin, invasive fungal infections, pneumonia, endocarditis, and febrile neutropenia.

Our featured speaker, Dr. Jaime Fergie, a pediatric infectious disease specialist, will review some of the published data and share his own insights on the optimal utilization of the Karius Test in fever of unknown origin.

Director Infectious Diseases, Driscoll Children's Hospital

The Power of Plasma Microbial Cell-Free DNA: Real World Application of a Liquid Biopsy for the Detection of Pathogens Associated with Fever of Unknown Origin

ASM 2024 Evening Event Panel - Unraveling the Mysteries of Infectious Diseases: The Role of Metagenomic Sequencing in Your Laboratory

This webinar will explore the application of metagenomic next-generation sequencing of plasma for the detection of invasive fungal infections. The Karius Test, a liquid biopsy for infectious diseases, utilizes a single blood sample to identify over 1000 pathogens for various diagnostic purposes, including invasive fungal infections, pneumonia, endocarditis, and febrile neutropenia. Our featured speaker, Dr. Martin Hoenigl, an infectious disease specialist and expert in the field of clinical mycology, will review some of the published data supporting use of the Karius Test for detection of pathogens associated with invasive fungal infections, including his own research on its diagnostic performance for COVID-19 associated pulmonary aspergillosis. He will also share insights on the optimal utilization of the Karius Test for invasive fungal infections.

Associate Professor of Translational Mycology, Division of Infectious Diseases - Medical University of Graz, Austria  Associate Professor of Medicine, Division of Infectious Diseases - University of California, San Diego (UCSD)

The Power of Microbial Cell-Free DNA: Real World Application of A Liquid Biopsy for Invasive Fungal Infections

The Power of Microbial Cell-Free DNA: Real World Application of a Liquid Biopsy for Endocarditis

IDWeek Presentation Theater - The Power of Plasma Microbial Cell-Free DNA: Real World Application of a Liquid Biopsy for Infectious Disease

Director of the Kawasaki Disease Clinic Rady Children's Hospital - San Diego

Infections Mimicking Systemic Inflammatory Diseases

Senior Director, Medical Advisor at Karius, Professor Emeritus, Department of Pathology and Laboratory Medicine, Medical University of South Carolina

Enhanced Clinical Metagenomic Testing: A Non-Invasive Liquid Biopsy for Infectious Diseases from Karius

Assistant Professor and Pediatric Intensivist at the University of California, San Diego and Rady Children's Hospital

Harnessing the Power of Microbial Cell-Free DNA in Plasma with the Karius Test to Detect Critical Infections

Assistant Professor of Medicine Transplant Infectious Diseases University of Colorado

The Karius Test in the Diagnosis and Management of Febrile Neutropenia

Use of the Karius Test in Immunocompromised Patients

The Karius Test® is a liquid biopsy for infection diseases that utilizes microbial cell-free DNA in plasma to detect over 1000 pathogens causing deep-seated and bloodstream infections. During his presentation Dr. Bergin will provide an overview of the Karius multi-center, prospective study comparing the Karius Test to Standard of Care in immunocompromised (IC) patients being evaluated for pneumonia. The population for this study are IC adults with hematological malignancies and/or (HCT) with suspicion of pneumonia. Results are expected later in 2022.

Media

Stay up-to-date with Karius